Search papers, labs, and topics across Lattice.
This paper introduces APLSuite, a novel software suite designed for predicting CD4+ T cell epitopes by integrating the Antigen Processing Likelihood (APL) algorithm with various biological metrics such as crystallographic B-factor and solvent accessible surface area. By addressing the limitations of existing supervised learning methods, APLSuite provides a streamlined, GPU-accelerated pipeline that significantly reduces computation time to mere minutes. The user-friendly interface and flexible deployment options make it accessible for both coding and non-coding researchers, enhancing its utility in immunology and immunotherapy development.
APLSuite slashes epitope prediction time to minutes while integrating critical biological factors often neglected by existing methods.
Computational epitope prediction is a critical tool for exploring and understanding CD4+ T cell-mediated immune responses, a key aspect of adaptive immunity. While existing computational methods primarily focus on supervised learning approaches, they often overlook the essential role of antigen processing in determining binding specificity. To address this limitation, our group developed Antigen Processing Likelihood (APL), an algorithm that integrates crystallographic B-factor, solvent accessible surface area (SASA), hydrogen exchange protection factors (COREX), and sequence entropy. In this paper we introduce APLSuite, a comprehensive and lightweight software suite designed to streamline APL-based epitope prediction. APLSuite integrates distributed RESTful API services, a Python client for data aggregation and processing, a data science tool for efficient epitope computation, and a user-friendly graphical user interface for non-coding users. It provides a seamless and efficient pipeline for APL calculation and epitope prediction that can be finished in minutes with GPU-acceleration, which has not been implemented by existed tools. This flexible and extensible software suite is deployable on desktop and cloud environments, offering both guided and customizable workflows to meet diverse research needs in immunology research and immunotherapy development.
